ArticlePediatric blood & cancer2023

Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors.

Hannah E Olsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.